Shamburg News · 8-K filed Nov 3, 2026, 8:19 AM EST
Guardant Health Grants Co-CEOs Performance-Based Restricted Stock Units Tied to Relative TSR
GH · Guardant Health, Inc.
- Leadership change
- Material agreement
- Materiality: medium
On November 2, 2026, the independent members of Guardant Health's Board approved performance-based restricted stock unit awards under the 2018 Incentive Award Plan to Co-Chief Executive Officers Helmy Eltoukhy and AmirAli Talasaz. Each Co-CEO received 465,413 target PSUs, eligible to be earned based on relative total shareholder return versus S&P 500 constituents over three-year (June 1, 2026 to May 31, 2029) and five-year (June 1, 2026 to May 31, 2031) performance periods, with payouts up to 250% of target. The form of award agreement is filed as Exhibit 10.1.
Source: SEC EDGAR, Form 8-K, Items 5.02, 9.01, accession 0001193125-26-444416.
Written from the filing by Shamburg Markets. Figures are as reported by the company.